cobas x00AE EBV
Total Payments
$272,471
Transactions
18
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $113,258 | 3 | 0 |
| 2023 | $105,167 | 12 | 0 |
| 2022 | $54,046 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $272,471 | 18 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RD006248 | ROCHE MOLECULAR SYSTEMS, INC. | $187,081 | 0 |
| RD006036 | ROCHE MOLECULAR SYSTEMS, INC. | $85,390 | 0 |
Top Doctors Receiving Payments for cobas x00AE EBV
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $272,471 | 18 |
Ad
Manufacturing Companies
- ROCHE MOLECULAR SYSTEMS, INC. $272,471
Product Information
- Type Device
- Total Payments $272,471
- Total Doctors 0
- Transactions 18
About cobas x00AE EBV
cobas x00AE EBV is a device associated with $272,471 in payments to 0 healthcare providers, recorded across 18 transactions in the CMS Open Payments database. The primary manufacturer is ROCHE MOLECULAR SYSTEMS, INC..
Payment data is available from 2022 to 2024. In 2024, $113,258 was paid across 3 transactions to 0 doctors.
The most common payment nature for cobas x00AE EBV is "Unspecified" ($272,471, 100.0% of total).
cobas x00AE EBV is associated with 2 research studies, including "RD006248" ($187,081).